Prophylactic vaccine to prevent cytomegalovirus disease

预防巨细胞病毒病的预防性疫苗

• 批准号: nhmrc : 1003885
• 负责人: Prof Rajiv Khanna
• 金额: $ 29.1万
• 依托单位: Queensland Institute of Medical Research
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/prophylactic-vaccine-prevent-cytomegalovirus-disease/108974
• 关键词: Prophylactic; vaccine; prevent; cytomegalovirus; disease

This project is aiming to develop a prophylactic vaccine against a common herpesvirus which has been linked to the birth defects in new born babies and significant morbidity and mortality in transplant patients. In this project we are testing a novel nanoparticle-based vaccine formulation which stimulates the immune system with single injection and the immunity induced is sustained for long-term.

该项目旨在开发一种针对常见疱疹病毒的预防性疫苗，这种病毒与新生儿的出生缺陷以及移植患者的严重发病率和死亡率有关。在这个项目中，我们正在测试一种新的基于纳米颗粒的疫苗制剂，它可以通过单次注射刺激免疫系统，并且诱导的免疫力可以长期持续。